Document is current
Any future updates will be listed below
-
Authors
dos Santos, José Carlos
Schäfer, Martin
Bauder-Wüst, Ulrike
Lehnert, Wencke
Leotta, Karin
Morgenstern, Alfred
Kopka, Klaus
Haberkorn, Uwe
Mier, Walter
Kratochwil, Clemens https://orcid.org/0000-0003-1334-8260
-
Funding
Funding for this research was provided by:
Richard-Winter-Stiftung (PhD scholarship)
- License Information
-
More Information
Article History
Received: 8 August 2018
Accepted: 19 November 2018
First Online: 3 January 2019
Compliance with ethical standards
:
: K.K, U.H and C.K.: patent for PSMA-617. J.C.dos S., M.S., U.B., U.H., W.M., C.K.: patent application for novel intellectual property presented in this article. All other authors declare no conflicts of interest.
: All procedures performed on animals were carried out in accordance with the laws on animal welfare of the Federal Republic of Germany and were approved by the local research committee.
: We report observations from clinical practice. Our institutional Ethics Committee certified (permit S-321/2012) that this retrospective evaluation complied with our national regulations and with the principles of the updated version of the Declaration of Helsinki. For this type of study clinical trial registration is not required.
: All patients were informed about the in-house production of the novel radiopharmaceutical according to the German Pharmaceuticals Act §13(2b), and gave written informed consent to their participation in this study.
